Hyperglycemia induces alterations in biochemical pathways such as the polyol pathway, increased flux of advanced glycation end products/receptors (AGE/RAGE), and the hexosamine pathway which contributes to an oxidizing environment and triggers a state of low chronic inflammation leading to progression of DR to advanced stages [3]. The gene discussed is AGER; the disease is Hyperglycemia.